DSI Syntoss is a synthetic, pure-phase β-Tricalcium Phosphate grafting material. The versatile bone graft comes in granules of various sizes, making it suitable for different surgical procedures, depending on the size and the location of the defect. The material is inert and does not cause immunogenic or toxic effects.
DSI Syntoss granules are optimized for bone regeneration and based on pure phase β - tricalcium phosphate, do not contain substances of animal origin, and have excellent biological compatibility with body tissues.
Many patients are not willing to use animal or cadaver tissue for a number of reasons, including religious or due to the risk of contamination.
DSI Syntoss is a superb alternative to traditional grafting materials offering multiple benefits. One of the most dangerous potential risks of natural grafts is disease transmission, which is easily avoided with DSI Syntoss. It eliminates the need for donor grafts for a faster and more predictable treatment.
Osteoconductive micro and macro porous composition fosters dense new bone growth. The structure allows vascularization and rapid bone regeneration. The optimal porosity of DSI Syntoss allows the granules to provide a space-maintaining scaffold while the new bone is formed, and it is completely resorbed simultaneously with formation of the bone without any other material embedded in the bone matrix.
A unique, engineered ionic release of calcium and phosphate ions results in the stimulation of families of genes that are known to be critical in the repair and regeneration of bone tissue.
DSI Syntoss will enhance patients’ comfort and confidence, ensuring fast treatment and successful results.
- Various sizes to suit the clinical situation
- Improved osteoconductivity
- Ideal resorption time
- No risk of disease transfer
- Extremely safe and effective
- Radiopaque due to the presence of calcium
- Completely resorbable
DSI Syntoss is used as an osteoplastic material to optimize bone regeneration in dental surgery, as well as in traumatology and orthopedics.